Bronchogenic cysts are congenital cystic lesions that arise due to anomalies in the development of the tracheobronchial tree during the embryonic period, and they are most commonly located in the mediastinal region. Although these cysts are often asymptomatic, they may become clinically apparent when located near critical anatomical structures such as the airway or esophagus (
4). Bronchogenic cysts adjacent to the trachea can cause symptoms such as dyspnea, stridor, recurrent pulmonary infections, and, in rare cases, tracheal deformation due to airway compression. Because of their anatomical proximity and frequent adhesion to surrounding tissues, cysts in this region pose technical challenges during surgical excision (
3).
Surgical excision remains the gold standard for the treatment of bronchogenic cysts, and in recent years, there has been an increasing preference for minimally invasive techniques (
5). Among these, u-VATS offers several advantages over traditional thoracotomy and multi-port VATS approaches, including reduced postoperative pain, lower complication rates, shorter hospital stays, better cosmetic outcomes, and earlier mobilization. Moreover, u-VATS has also been shown to be a safe and reliable technique even in complex surgical scenarios (
6,
7).
Studies have demonstrated that u-VATS is both a safe and effective approach for the excision of bronchogenic cysts. When applied to mediastinal lesions, u-VATS has been associated with low morbidity rates, and the majority of resulting complications have been successfully managed using conservative methods (
8). The same studies have also reported significantly shorter operative times and drainage durations. Moreover, even in cases where bronchogenic cysts are located in close proximity to high-risk anatomical structures such as the trachea, successful excision using the u-VATS technique has been documented when performed by experienced surgeons (
9).
The primary surgical risk in bronchogenic cysts located adjacent to the trachea is the development of tracheal injury during dissection. This complication becomes particularly inevitable when dense adhesions secondary to inflammation are present. However, cases in the literature have shown that tracheal injuries occurring during u-VATS can be successfully repaired with primary suturing, without the need to convert to open thoracotomy (
10,
11). Several studies have confirmed that tracheal ruptures can be safely managed within the scope of minimally invasive surgery. This demonstrates that u-VATS is not only an excision technique but also a reliable and effective method for managing intraoperative complications.
The present case is noteworthy as it illustrates the successful excision of a bronchogenic cyst adjacent to the trachea using the u-VATS technique, along with the primary repair of an intraoperative tracheal rupture through the same minimally invasive approach. This highlights the fact that minimally invasive surgery, beyond offering cosmetic and comfort-related advantages, also serves as a robust option for addressing complex surgical complications.
3.1. Conclusions
Bronchogenic cysts can pose significant diagnostic and therapeutic challenges, particularly when located adjacent to critical structures such as the trachea. With advancements in minimally invasive surgical techniques, u-VATS has emerged as an effective and safe alternative for both diagnostic and therapeutic interventions. Proper patient selection, meticulous dissection, and techniques performed by experienced surgeons have contributed to minimizing complication rates associated with u-VATS.
This case contributes to the literature by demonstrating the successful excision of a bronchogenic cyst located adjacent to the trachea using the u-VATS technique, along with the primary repair of an intraoperative tracheal injury through the same approach. Beyond its well-recognized advantages in terms of postoperative comfort, u-VATS proves to be a robust tool in managing complex intraoperative complications. Cases such as this underscore that, in appropriately selected patients, u-VATS can achieve high success rates without the need for conversion to open surgery.